Subscribe To
: lexeo therapeutics’ stock falls 15% in trading debut after its ipo priced below range
Lexeo Therapeutics Inc.’s stock LXEO tumbled 15% in its trading debut on Friday, after the company’...
November 4, 2023, 4:29 pm
Kymera therapeutics, inc. (kymr) q3 2023 earnings call transcript
Kymera Therapeutics, Inc. (NASDAQ:KYMR ) Q3 2023 Earnings Call Transcript November 2, 2023 8:00 AM ET C...
November 4, 2023, 1:10 pm
10 ways costco is cheaper than sam's club
In the realm of retail giants, Costco and Sam's Club stand out as the titans of bulk sales....
November 4, 2023, 12:00 pm
Candel therapeutics presents preclinical data from its enlighten™ discovery platform at sitc
The first experimental agent from the enLIGHTEN™ Discovery Platform is Alpha-201-macro1, an investigational viral immunotherapy designed to activate...
November 4, 2023, 12:00 pm
Seres therapeutics, inc. (mcrb) q3 2023 earnings call transcript
Seres Therapeutics, Inc. (NASDAQ:MCRB ) Q3 2023 Results Conference Call November 2, 2023 8:00 AM ET Com...
November 4, 2023, 11:52 am
Atara biotherapeutics, inc. (atra) q3 2023 earnings call transcript
Atara Biotherapeutics, Inc. (NASDAQ:ATRA ) Q3 2023 Results Conference Call November 1, 2023 9:00 AM ET ...
November 4, 2023, 11:45 am
India's economic rise demands investor attention
By Angus Shillington, Deputy Portfolio Manager, Emerging Markets Equity and John Patrick Lee, CFA, Product Manager India's rapid digitization, thrivin...
November 4, 2023, 11:29 am
Gold and white papers
The long-term benefit seems lucrative. There are other short term gains that are achievable when using gold for trade. Digital art is accurately value...
November 4, 2023, 10:44 am
Lisata therapeutics, inc. (lsta) q3 2023 earnings call transcript
Lisata Therapeutics, Inc. (NASDAQ:LSTA ) Q3 2023 Results Conference Call November 2, 2023 4:30 PM ET Co...
November 4, 2023, 10:27 am
Coterra energy: an oil and gas superstar at a discount
The oil and gas industry is expected to enter a new supercycle, driven by geopolitical tensions, accumulated underinvestment in c...
November 4, 2023, 7:42 am
1 under-the-radar stock that could triple by 2030
Viking Therapeutics is looking to profit from the expanding market for obesity drugs. The company's two...
November 4, 2023, 7:30 am
China ev maker byd to build first europe plant in hungary -fas
Chinese electric vehicle giant BYD , plans to build its first European car factory in Hungary, a German newspa...
November 4, 2023, 6:59 am
Kefi gold and copper: a comprehensive update on operational progress and market dynamics - icymi
In this interview, Thomas Warner from Proactive chats with Harry Anagnostaras-Adams, the executive chairman of KEFI Gold and Copper PLC (AIM:KEFI, OT...
November 4, 2023, 5:29 am
Shareholder investigation: halper sadeh llc investigates miro, src, doc
NEW YORK, Nov. 04, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential vio...
November 4, 2023, 4:00 am
Otlk investor alert: robbins geller rudman & dowd llp announces that outlook therapeutics, inc. investors with substantial losses have opportunity to lead the outlook therapeutics class action lawsuit
SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that the Outlook Ther...
November 4, 2023, 12:13 am
Autolus therapeutics plc (autl) q3 2023 earnings call transcript
Autolus Therapeutics plc (NASDAQ:AUTL ) Q3 2023 Earnings Conference Call November 2, 2023 9:00 AM ET Co...
November 3, 2023, 10:05 pm
Vida markets expands trading horizons: mt4 and mt5 access now available
The global brokerage firm Vida Markets is offering a dual access to the MT4 and MT5 platforms. This update is a leap toward reshaping how the broker's...
November 3, 2023, 8:58 pm
Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance
In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational ther...
November 3, 2023, 8:30 pm
Aligos therapeutics to host kol event to discuss alg-000184 phase 1, aasld late breaker data
November 16 Event to feature KOL perspective on Emerging HBV Therapies SOUTH SAN FRANCISCO, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) — Aligos Ther
November 3, 2023, 8:30 pm
Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance
In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational ther...
November 3, 2023, 8:30 pm